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1. General information 
Text adopted from.25 The starting compounds and solvents were purchased from Sigma-
Aldrich/Fluka, ABCR, TCI Chemicals or Acros and were used without further purification. For 
reactions under inert gas conditions, the solvents (dichloromethane and chloroform) were dried 
over molecular sieves 4 Å and degassed afterwards. Column chromatography was carried out 
using 230−400 mesh, 60 Å silica gel (Brunschwig). TLC plates (Merck, Silica gel 60 F254) were 
developed with KMnO4-solution.  
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 H, 13C and 31P NMR spectra were recorded (as indicated) on 
either a Bruker 300 or 400 MHz spectrometer and are reported as chemical shifts in ppm relative 
to TMS, calibrated to the signal of the deuterated NMR-solvent. Spin multiplicities are reported 
as singlet (s), doublet (d), triplet (t), with coupling constants (J) given in Hz, or multiplets (m). 
Broad peaks are marked as br. HRESI-MS was performed on a QSTAR Pulsar (AB/MDS Sciex) 
spectrometer and are reported as mass-per-charge ratio m/z. IR spectra were recorded on a 
PerkinElmer Spectrum One FT-IR spectrometer (ATR, Golden Gate). 
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2. Synthesis of heptadecanoyl chloride (6) 
 
 
Heptadecanoic acid (8.114 g, 30 mmol) and thionyl chloride (7.138 g, 60 mmol) were placed in a 
round bottom flask, 3 drops of DMF were added and the mixture was heated to reflux for 4 h. 
The solvents were removed under reduced pressure. The crude product was distilled (1.0x10-
1 mbar, 155 °C) yielding 6.24 g (21.6 mmol, 72 %) of the product.  
 
1H-NMR: (300 MHz; CDCl3, δ): 2.88 (t, 2H), 1.71 (quin, 2H), 1.26 (s br, 26H), 0.88 (t, 3H). 
13C-NMR: (75 MHz; CDCl3, δ): 174.1, 47.3, 32.1, 29.8, 29.7, 29.5, 29.2, 28.5, 25.2, 22.8, 14.3. 
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Figure S1: 1H-NMR of heptadecanoyl acid chloride. 
 
Figure S2: 13C-NMR of heptadecanoyl acid chloride.  
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3. Synthesis of tert-butyl (2-((amino((1,3-diheptadecan-
amidopropan-2-yl)oxy)phosphoryl)oxy)ethyl)carbamate (7)  
 
To the dichlorophosphoramidite (1.0 g, 2.9 mmol) dissolved in DMSO (50 mL) NaN3 (0.5 g, 
7.7 mmol) was added and it was heated to 100 °C for 15 h. Afterwards it was cooled to RT. Brine 
(60 mL) was added and the solution was extracted with Et2O (4 x 50 mL). The combined organic 
phases were dried over Na2SO4. MeOH (100 mL) was added and Et2O was removed under 
reduced pressure. The crude diazide, still solved in MeOH, was used without further purification.  
Palladium on charcoal (150 mg) was added to the solution of the crude product in MeOH. H2 
was bubbled through the solution (one filled balloon). Afterwards, a second balloon filled with 
H2 was added and the solution was stirred overnight. To remove the Pd-catalyst the solution was 
filtered over celite and washed with MeOH (3 x 30 mL). The solvent was removed under reduced 
pressure. The resulting crude diamine was used without further purification. 
The crude product was dissolved in DCM (20 mL) and NEt3 (1.4 mL, 9.8 mmol) was added. The 
reaction mixture was cooled to 0 °C and heptadecanoyl chloride (2.83 g, 9.8 mmol) was added 
and the mixture was stirred over night at RT. The solvent was removed under reduced pressure 
and the crude product was purified by silica gel column chromatography (EtOAc). The product 
was isolated as a white wax (1.256 g, 1.54 mmol, 53 %). 
 
1H-NMR: (300 MHz; CDCl3, δ): 7.00 (br s, 1H), 6.86 (br s, 1H), 5.25 – 5.50 (m, 1H), 4.34 – 4.46 
(m, 1H), 4.02 – 4.17 (m, 1H), 3.51 – 3.63 (m, 2H), 3.31 – 3.50 (m, 4H), 2.26 (t, 3JHH = 7.6 Hz, 
4H), 1.65 (quin, 3JHH = 7.5 Hz, 4H), 1.46 (s, 9H), 1.34 (br s, 2H), 1.28 (s, 52H), 0.90 (t, 
3JHH = 13.4 
Hz, 6H). 
13C NMR (75 MHz, CDCl3, δ): 175.3, 160.7, 66.1, 65.6, 47.7, 40.9, 36.7, 31.9, 29.7, 29.5, 29.4, 
29.3, 28.4, 25.8, 22.7, 14.1. 
31P-NMR: (121 MHz; CDCl3, δ): 9.4.  
HRMS (ESI+): m/z [M+Na]
+ calcd for [M+Na]+ 839.6361; found, 839.6361. 
IR 2927, 2855, 1659, 1550, 1252, 1240, 1069, 1006, 979 cm-1. 
Rf (DCM / MeOH / H2O, 65 : 25 : 4): 0.83. 
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4. Synthesis of 1,3-diheptadecanamidopropan-2-yl (2-
(trimethylammonio)ethyl) phosphate (Rad-PC-Rad, 4) 
 
N-Boc protected Rad-phosphatidyl ethanolamine-Rad (1.13 g, 1.4 mmol) was dissolved in HCl in 
Et2O (1 M, 20 mL + 0.5 mL water). The solution was stirred for 2 h and afterwards the solvents 
were removed under reduced pressure.  
The deprotected product was used without any further purification and was dissolved in MeOH 
(100 mL) and dimethyl sulfate (1.0 mL, 1.33 g, 10.5 mmol) was added. The mixture was heated to 
40 °C and then a solution of potassium carbonate (1.45 g, 10.5 mmol, in H2O (20 mL)) was 
added, while it was stirred heavily and afterwards the solution was stirred for 1 h at 40 °C. 
Afterwards the solvents were removed under reduced pressure. The product was purified by 
silica column chromatography (DCM / MeOH / H2O, 65:25:4), yielding a white powder (0.76 g, 
1.0 mmol). The crude product was further purified by precipitation from CHCl3 / MeOH (1:1) 
with acetone and by sephadex LH20 column chromatography (DCM / MeOH / H2O, 
65 : 25 : 4). A white powder was obtained (0.76 g, 0.99 mmol, 71 %). 
 
1H-NMR (400 MHz; CDCl3, δ): 7.85 (s, 2H), 4.57 (s, 2H), 4.29 (s, 1H), 4.01 (s, 2H), 3.49 (s, 2H) 
3.40 (s, 9H), 3.26 (s, 2H), 2.24-2.21 (m, 4H), 1.60-1.55 (m, 4H), 1.25 (s, 52H), 0.87 (t, 3JHH = 6.7 
Hz, 6H). 
13C NMR (101 MHz, CDCl3, δ): 175.5, 72.8, 66.1, 59.8, 54.2, 40.1, 36.5, 32.0, 30.0, 30.0, 29.9, 
29.9, 29.8, 29.7, 29.6, 29.5, 26.2, 22.9, 22.7, 14.1. 
31P-NMR (121 MHz; CDCl3, δ): -1.6.  
HRMS (ESI+) : m/z [M+H
+] : calcd for [M+H] : 760.6333; found: 760.6331. 
IR 3130, 3042, 2915, 2848, 1645, 1402, 1224, 1044 cm-1. 
Rf (DCM / MeOH / H2O, 65 : 25 : 4): 0.48. 
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Figure S6: 1H-NMR of Rad-PC-Rad (4). 
 
 








5. Differential scanning calorimetry 
Text adopted from.25 Multilamellar vesicle suspensions were prepared by hydration of 1 mg of 
phospholipid powder with 1 mL of ultra pure water (18.2 MΩ·m). The unextruded vesicle 
suspensions were degassed for 30 minutes using a TA degassing station. The alternative heating-
cooling scans were recorded on a TA Nano DSC (TA Instruments, USA) from 5 °C to 90 °C 
with a scanning speed of 0.5 K/min. The experiment was performed twice, starting with new 
suspensions, in order to ensure reproducibility. The scans of the second heating-cooling scans are 
reported. Raw data was base-line corrected and converted to molar heat capacity (MHC) using 
the NanoAnalyze software (TA Instruments, USA). The main phase transition and enthalpy were 
determined with the same software and verified using the Origin software (OriginLab, 
Northampton, USA).  
 
Figure S9: Differential scanning calorimetry heating- (orange) and cooling-curve (blue) of MLV 
suspensions with a heating-/cooling-rate of 0.5 K/min. The main phase transition temperature of 
Tm = 44.7 °C with an enthalpy change of ∆H: 22.6 kJ/mol; cooling Tm = 42.9 °C with an 
enthalpy change of ∆H: 24.1 kJ/mol. 
 
6. Vesicle preparation 
Text adapted from.25 LUVET100 of Rad-PC-Rad (4) were prepared following the standard 
extrusion protocol: In a 25 ml round bottom flask, 10 mg of the lipid were dissolved in CH2Cl2. 
After evaporation of the organic solvent, the film was further dried under high vacuum (40 mbar) 
overnight. Then the film was hydrated with the internal buffer for 30 min. (1 ml, 50 mM 5(6)-
carboxyfluorescein, 10 mM HEPES buffer (AppliChem), 10 mM NaCl dissolved in pure water, 
pH 7.4 (NaOH)). Now at least 5 freeze-thaw cycles (liquid N2 to 65 °C) were carried out before 
the suspension was extruded 11 times using a Mini Extruder (Avanti Polar Lipids, USA) using 
track-edged filters with a mesh size of 100 nm (Whatman, USA). The external buffer was then 
exchanged on a size exclusion column (1.5 × 20 cm Sephadex G-50 column) in external buffer 
(107 mM NaCl, 10 mM HEPES dissolved in ultrapure water, pH 7.4 (NaOH)).  
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7. Cryogenic transition electron microscopy 
Text adopted from.9 LUVET100 of Rad-PC-Rad (4) were prepared by the extrusion protocol 
described above at a concentration of 10 mg/ml. The liposome suspensions were let to reach 
room temperature and were diluted 1:1 with isotonic saline and were mounted on glow-
discharged holey carbon grids, quickly frozen by a Cryoplunge 3 system (Gatan, USA) and 
transferred to a JEM2200FS transmission electron microscope (JEOL, Japan) using a Gatan626 
cryo-holder. Cryo-transmission electron micrographs were recorded at the acceleration voltage of 
200 kV, x 20,000 magnification, 4-8 µm underfocus and a dose of 10 electrons/Å2, using a F416 
CMOS detector (TVIPS, Germany). The final concentration of the liposomal suspension used 
was 5 mg/ml or 6.3 mM. The thickness of the bilayer was measured using the open source 
software Fiji.30-32 The membrane thickness for spherical vesicles is 5.324 nm ± 0.447 nm (N=502) 
and for two stacked bilayers 8.491 nm ± 0.624 nm (N=148). 
 
  
Figure S10: Overview cryoTEM image and colored vesicles for statistical evaluation of the 
spherical to facetted ratios (orange facetted; green spherical) (scale bars are 200 nm long). 
 
  
Figure S11: CryoTEM images zoomed in to different sections of the full image to highlight some 




Figure S12: Membrane thickness distribution of N = 509 membrane cuts through Rad-PC-Rad 
containing vesicle membranes (see Figure S10) and a Gaussian fit.  
 13
8. Release experiments 
Text adopted from.25 The inner buffer (CF buffer) was prepared from 50 mM 5(6)-
carboxyfluorescein (powder, Sigma-Aldrich) and 10 mM HEPES buffer (powder, Sigma-Aldrich) 
dissolved in ultra-pure water (18.2 MΩcm). The pH was adjusted to 7.4 (NaOH) and the 
osmotic concentration to 200 mOsmL–1 (NaCl). The outer buffer was prepared from 10 mM 
HEPES buffer (powder, Sigma-Aldrich) dissolved in ultra-pure water (18.2 MΩcm). The pH 
was adjusted to 7.4 (NaOH) and the osmotic concentration to 200 mOsmL–1 (NaCl). Rad-PC-
Rad (4) (2 mg) was weighed into a round-bottomed flask (25 mL) and dissolved in CHCl3 (1 ml, 
amylene stabilized, Sigma-Aldrich, USA). The solvent was removed by low-pressure rotatory 
evaporation. The thin film was dried under high vacuum overnight, to ensure the removal of 
residual water and prevent cholesterol oxidation. Inner buffer (1 mL) was added to the round- 
bottomed flask and the film was hydrated for 30 minutes at 65 °C. The film was subjected to five 
cycles of freeze/thaw using liquid nitrogen and a 65 °C water bath. The resulting MLV 
suspension was extruded 11 times through a track-etched filter membrane at 65 °C (100 nm, 
Whatman, USA) placed in a Mini Extruder (Avanti Polar Lipids, USA). The vesicles were left 
standing at room temperature overnight. The residual non-encapsulated CF buffer, in the 
LUVET100 suspension, was exchanged with the outer buffer using size exclusion chromatography 
(PD-10 desalting columns, GE Healthcare, UK). The size exclusion chromatography was carried 
out after 24 hours storage, in the dark at room temperature, of the LUVET100 suspension. 
 
The purified LUVET100 suspension was diluted, in a volumetric flask, to 100 mL using additional 
outer buffer. Six aliquots (2 mL) were separated into vials (5 ml, PE caps) and vortex mixed for 
different amounts of time (0, 5, 10, 20, 30, 60 s) at 2500 rpm. The 5(6)-carboxyfluorescein release 
was quantified using a fluorospectrometer (Sense 425-301, Hidex, Finland). For each sample, five 
microplate wells were filled with 200 µl of the vortex 20 mixed vesicular suspension. The 
wavelengths used for measurements were 485 nm (excitation) and 535 nm (emission). As a 
control for the maximum dye release (F100), a Triton X-100 solution (2 µl of a 10 vol% solution) 
was added to additional five microplate wells, filled with 200 µl of vesicular suspension, for each 







where FX is the fluorescence at time X, F0 the fluorescence at time zero and F100 the maximum 
fluorescence recorded after treatment with Triton X-100. 
The data were fitted according to simple release kinetics, using the software pro Fit 7.0.11 
(QuantumSoft, Uetikon am See, Switzerland). The time dependence of the drug release R = R(t) 
can be perfectly described by the use of the time constant τ and the release amplitude R0 as the 
two fitting parameters in the following equation: 
 






Figure S13: Long-term release of 5(6)-Carboxyfluorescein containing vesicles formulated from 
Pad-PC-Pad (2), Rad-PC-Rad (4) and DPPC (1) respectively. The formulations have been stored 
at 22 °C for 7 days. 
 
9. Film balance measurements 
Text adapted from.25 Pressure-area isotherms were recorded on a computer interfaced Langmuir 
trough with a surface area of 194 cm2 (Riegler & Kierstein, Potsdam, Germany). The paper plate 
Wilhelmy method was used to measure the surface tension with an accuracy of ±0.1 mN/m. 
Each measurement was repeated at least three times. The Langmuir trough was filled with 
ultrapure water (specific resistance of 18.2 MΩcm). The lipid solution (1 mg/ml) in chloroform 
was spread and the measurement was started 5–15 min after spreading. The compression speed 
was 3.12 cm2min-1. 
 
Figure S14: Tm (main phase transition temperature for a bilayer), Tc (critical temperature for a 
monolayer) and T0 (minimum transition temperature for a monolayer) versus fatty acyl chain 
length of 1,3-disubstituted diamido phospholipids Pad-PC-Pad (2), Rad-PC-Rad (4) and Sad-PC-
Sad (3). 
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10. Grazing incidence X-ray diffraction measurements 
Text adapted from.25 The monolayer’s lattice structure was investigated by grazing incidence x-ray 
diffraction (GIXD) measurements performed at the PETRA III beamline P08 at the German 
Synchrotron DESY-Hamburg, Germany. A photon source with an energy of 15 keV was used 
for the measurements. The monolayers were prepared on a Langmuir-Pockels trough on an 
antivibrational table with a fully extended area of 450 cm2 and 300 mL subphase volume at 295 K 
air temperature and different subphase temperatures between 10–25 °C. Throughout the whole 
measurement, the trough chamber was flushed with wet Helium. A linear position-sensitive 
MYTHEN detector system (PSI, Villigen, Switzerland) measured the diffracted signal and was 
rotated around the trough to scan the in-plane Qxy component values of the scattering vector. To 
restrict the in-plane divergence of the diffracted beam a Soller collimator was placed in front of 
the MYTHEN detector, the resulting divergence was 0.09°. The vertically distributed pixels of 
the MYTHEN measured the out-of-plane Qz component of the scattering vector between 0.0 
and 1.2 Å−1. The intensities of the scattered radiation were corrected for polarization, footprint 
area, and powder averaging.  Model peaks taken to be Lorentzians in the in-plane direction 
(Bragg peaks) and Gaussians in the out-of-plane direction (Bragg rods) were fitted to the 
measured intensities. The in-plane lattice repeat distances d of the ordered structures in the 










Figure S16: Dependence of the tilt angle of the alkyl chains (t) represented as 1/cos(t) on the 
lateral surface pressure (̟) at 20 °C. 
 
 
Figure S17: Selected GIXD heatmaps of the diffraction intensities as a function of the in-plane 
Qxy and out-of-plane Qz components of the scattering vector Q for Rad-PC-Rad (4) at 10 °C and 
30 mN/m (left) as well as 20 °C and 30 mN/m (right). 
 
 
 
